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Muramidase-released protein (MRP) is as an important virulencemarker of Streptococcus
suis (S. suis) serotype 2. Our previous works have shown that MRP can bind human
fibrinogen (hFg); however, the function of this interaction in S. suismeningitis is not known.
In this study, we found that the deletion of mrp significantly impairs the hFg-mediated
adherence and traversal ability of S. suis across human cerebral microvascular endothelial
cells (hCMEC/D3). Measurement of the permeability to Lucifer yellow in vitro and Evans
blue extravasation in vivo show that the MRP-hFg interaction significantly increases the
permeability of the blood–brain barrier (BBB). In the mouse meningitis model, wild type S.
suis caused higher bacterial loads in the brain and more severe histopathological signs
of meningitis than the mrp mutant at day 3 post-infection. Western blot analysis and
immunofluorescence observations reveal that the MRP-hFg interaction can destroy the
cell adherens junction protein p120-catenin of hCMEC/D3. These results indicate that
the MRP-hFg interaction is important in the development of S. suis meningitis.
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Introduction
Streptococcus suis (S. suis) serotype 2 is an important emerging zoonotic pathogen that can cause
meningitis, endocarditis, arthritis, pneumonia, bacteremia, and sudden death in swine and humans
(Segura, 2009). Sporadic cases of S. suis infection in humans have been reported in several European
and Asian countries as well as in North and South America, Australia, and New Zealand. This
bacterium can affect not only the workers in close contact with pigs or swine byproducts but also the
general population. Meningitis is the most important clinical feature associated with S. suis infection
in human, with high morbidity and mortality. In China, the outbreak of S. suis serotype 2 in 2005
resulted in more than 200 human cases of infection with a fatality rate near 20% (Yu et al., 2006).
In Vietnam, S. suis was the most frequent cause of bacterial meningitis in adults (Hoa et al., 2013).
Meningitis caused by S. suis likely develops through a multi-step process of bacteria-host interaction
(Gottschalk and Segura, 2000; Gottschalk et al., 2010). Individuals can be infected through skin
lesions or the oral route followed by invasion, bacteremia and septicemia with or withoutmeningitis.
Bacteria reach central nervous system by crossing the blood–brain barrier (BBB) which is mostly
composed of brain microvascular endothelial cells. The effect of the interactions between specific S.
suis virulence factors and host factors at the BBB is not understood.
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The blood protein fibrinogen is synthesized primarily in
the liver under normal conditions (Herrick et al., 1999) and
interacts with a number of integrin and non-integrin receptors
expressed on many cell types in the hematopoietic, immune
and nervous system using multiple non-overlapping sites. For
example, fibrinogen can bind glycoprotein IIb-IIIa (GPIIb-
IIIa) on the surface of agonist-stimulated platelets leading to
platelet aggregation (Bennett, 2001). Additionally, fibrinogen
can bind to CD11b/CD18 expressed on cells of the immune
system and cause a broad spectrum of cell signaling responses,
such as activation of NF-kB and mitogen-activated protein
kinase (MAPK)/phosphatidylinositol 3-kinase (PI3K) to mediate
adhesion, migration, chemotaxis, and phagocytosis (Ryu et al.,
2009). Fibrinogen can also mediate diseases by bridging the
surface proteins of pathogen in the bloodstream or within tissues.
In recent years, many cell wall proteins in gram-positive bacteria,
such as the M protein of Group A streptococci (Whitnack and
Beachey, 1985), FbsA of S. agalactiae (Tenenbaum et al., 2005),
FnbpAof S. aureus (Wann et al., 2000), ClfA of S. aureus (Josefsson
et al., 2001), SdrG of S. epidermidis (Davis et al., 2001) have been
shown to interact with fibrinogen and play different biological
functions in pathogenesis.
Muramidase-released protein (MRP) was discovered as a factor
released from virulent S. suis serotype 2 strains after muramidase
treatment (Smith et al., 1992). Differences in the expression
of MRP and extracellular factor (EF) are associated with the
virulence of S. suis serotype 2 strains, but an intranasal infection
model using newborn germfree pig showed that the isogenic
mrp mutant was as virulent as the wild-type strain (Smith et al.,
1996). Therefore, MRP was thought to be an important virulence
marker but not a critical virulence factor for S. suis serotype 2.
However, our recent in vitro study found that MRP could bind
to human fibrinogen (hFg) and, promote the anti-phagocytosis of
S. suis serotype 2 to neutrophils thereby enhancing the survival of
bacteria in human blood (Pian et al., 2015). These results indicate
that MRP might have undiscovered functions. The biological
functions of MRP binding to fibrinogen in S. suis meningitis has
not been investigated.
In the present report, we show that hFg increases the adherence
and traversal ability of S. suis to hCMEC/D3 cell monolayer.
In addition, we provide evidence that the MRP-hFg interaction
increases the permeability of the BBB by destroying the stability of
p120-catenin, resulting in the development of S. suismeningitis.
Materials and Methods
Ethics Statement
CD1 mice (female, 6 to 8 weeks-old) were used in this study.
All animals were purchased from the animal center of the
Academy of Military Medical Sciences (AMMS) and housed
under SPF condition. Animals were cared for in accordance
with the principles of laboratory animal care approved in China.
All experimental procedures were approved by the Institutional
Animal Care and Use Committee of AMMS.
Bacterial Strains, Cell, and Culture Conditions
The S. suis strain 05ZYH33 and the isogenic deletion mutant
05ZYH33D mrp used in this study were cultured as previously
described (Geng et al., 2008). The mutant 05ZYH33Dmrp
was constructed by targeted gene allelic replacement with a
constitutively expressed chloromycin resistance cassette as we
previously described (Pian et al., 2012). The immortalized
human cerebral microvascular endothelial cells (hCMEC/D3)
were donated by Professor Pierre-Olivier Couraud (INSERM,
Paris) and cultured by previously described methods (Weksler
et al., 2013).
Adherence Assay
Adherence of S. suis to hCMEC/D3 cells was assayed as previously
described with some modifications (Tenenbaum et al., 2005).
Briefly, hCMEC/D3 cells were cultured in 96-well tissue culture
plates at a seeding density of 1  104 cells per well and grown
until confluent. The cell culture medium was replaced with EBM-
2 complete medium without antibiotics 24 h before infection.
After washing once with PBS, log-phase S. suis was resuspended
in EBM-2 completemediumplus recombinant hirudin (70U/mL)
without antibiotics and adjusted to 106 CFU/mL. The bacteria
were incubated with a series of concentrations of hFg for 1 h
at 37°C with rotation, and then added to hCMEC/D3 cell
monolayers at a multiplicity of infection (MOI) of 10:1 for 2 h
at 37°C in 5% CO2. The cell monolayers were washed four times
with PBS and then lysed with 0.1% saponin on ice for 20 min.
The number of cell-adherent bacteria was determined by plating
appropriate dilutions of the lysate on THB agar plates. Bacterial
adherence was calculated as (recovered CFU/initial inoculum
CFU) 100%.
Fluorescent Microscopy
HCMEC/D3 cells were grown until confluent on 12-mmdiameter
glass coverslips coated with 5 mg/cm2 of rat tail collagen type I.
The cells were grown in EBM-2 medium with 0.25% FBS and
hirudin (70 U/mL) without antibiotics 24 h before infection.
Log-phase S. suis was pre-incubated with hFg for 1 h and then
added to the hCMEC/D3 cell monolayers at a MOI of 100:1 for
25 min. After infection, hCMEC/D3 cells were fixed with 3.7%
paraformaldehyde for 20 min at RT and then permeabilized with
0.1% Triton X-100 for 15 min. After blocking with 1% BSA for
1 h, hCMEC/D3 cells were stained with rabbit anti-p120-catenin
antibody (Santa Cruz, CA, USA, 1:100 dilution in 0.3% BSA) and
Alexa Fluor 594-conjugated goat anti-rabbit antibody (Invitrogen,
CA, USA, 1:200 dilution in 0.3% BSA). Coverslips were mounted
on glass slides with DAPI (Vector Labs) and observed with a
confocal laser scanning microscope (FV1000, Olympus).
For adherence assays, confluent hCMEC/D3 cell monolayers
on glass coverslips were grown in EBM-2 medium containing
0.25% FBS and hirudin (70U/mL) with or without exogenous hFg
3 h prior to bacterial infection. Log-phase S. suis 05ZYH33 and
05ZYH33Dmrp were labeled with BCECF for 30 min and then
added to the cell monolayers at aMOI of 100:1 for 2 h. After gently
rinsing three times with PBS, hCMEC/D3 cells were fixed and
permeabilized as described above. Cell monolayers were stained
with 100 nM Rhodamine-labeled Phalloidin (Cytoskeleton, Inc.)
for 1 h at room temperature and mounted on glass slides with
DAPI.
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FIGURE 1 | MRP-hFg interaction promotes the adherence of S. suis to hCMEC/D3 cells. (A) The adherent ratio of S. suis to hCMEC/D3 cells in the presence
of hFg. S. suis 05ZYH33 and 05ZYH33Dmrp mutant were pretreated with a series of concentrations of hFg before infecting a hCMEC/D3 cell monolayer. The
adherence ability of S. suis was evaluated by adherence assay. Values represent percent (mean  S.D.) of total S. suis inoculum bound to the monolayers. (B) The
adherent ability of S. suis to hCMEC/D3 cells evaluated by fluorescent microscopy. S. suis 05ZYH33 and 05ZYH33Dmrp mutant were labeled by BCECF (green)
before infection, and hCMEC/D3 cell monolayers were treated or untreated with Fg (500 mg/ml). F-actin was strained with Rhodamine-labeled Phalloidin (red), nuclei
were stained with DAPI (blue). *P < 0.05.
Streptococcus suis Transendothelial Migration
Assay
For transendothelial migration assays, hCMEC/D3 cells were
grown until confluent on 3 mm pore size Millicell® (Millipore)
inserts as previously described (Vu et al., 2009). The culture
medium was EBM-2 medium supplemented with 0.25% FBS and
hirudin (70 U/mL) without antibiotics 24 h before infection. The
confluent cell monolayers were pretreated with or without hFg (20
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FIGURE 2 | MRP-hFg interaction increases the traversal ability of S. suis across the hCMEC/D3 cell monolayer. (A) The traversal rate of S. suis across the
hCMEC/D3 monolayers. Confluent hCMEC/D3 cell monolayers pretreated with or without Fg were challenged with S. suis 05ZYH33 and 05ZYH33Dmrp for 25 min.
The traversed bacteria in the basolateral chamber were enumerated by colony plate count. (B) The transendothelial permeability assay. Fg pretreated S. suis
05ZYH33 or 05ZYH33Dmrp were incubated with hCMEC/D3 cell monolayers in the presence of Lucifer yellow (200 mM) for 30 min. The amount of Lucifer yellow in
the basolateral chamber was quantified with a spectrophotometer. D-mannitol was used as positive control as it disrupts cell–cell junctions. *P < 0.05, **P < 0.01.
mg/mL) for 3 h and then challenged with log-phase S. suis at a
MOI of 100:1 for 25 min. The number of traversal bacteria was
determined by plating appropriate dilutions of the basal chamber
medium on THB agar plates. The traversal rate of S. suis across
the cell monolayer was calculated as (CFU in the basal chamber
/initial inoculum CFU in apical chamber) 100%.
Measurement of Permeability to Lucifer Yellow
HCMEC/D3 cells were grown until confluent on 0.4 mm pore
size MilliCell® inserts in 24-well cell plates. Log-phase S. suis was
incubated with hFg (20 mg/ml) for 1 h and then added to the
hCMEC/D3 cell monolayers at a MOI of 100:1. At the same
time, Lucifer yellow (200 mM, Invitrogen) was added to the apical
chamber and incubated in transport buffer (EBM-2 medium
supplemented with 10 mM HEPES and 1 mM sodium pyruvate)
for 30 min. The amount of Lucifer yellow in the basolateral
chamber was quantified with a spectrophotometer (Varioskan
Flash, Thermo Fisher).
Western Blotting Analysis
Streptococcus suis strains 05ZYH33 and 05ZYH33Dmrp were
pre-incubated with hFg for 1 h and added to hCMEC/D3 cell
monolayers at a MOI of 100:1 for indicated time. Cell monolayers
were washed three times with ice-cold PBS and lysed with 50 mM
Tris pH 7.5, 10 mM MgCl2, 0.5 M NaCl, 2% Igepal, complete
mini protease inhibitors and phosphatase inhibitors (Roche)
on ice for 20 min. Cell lysates were separated by SDS-PAGE
electrophoresis and transferred to nitrocellulose membranes.
Membranes were incubated with primary antibodies and
appropriate HRP-conjugated secondary antibodies. The protein
signals were developed with SuperSignal West Dura Extended
Duration substrate (Pierce) and imaged using ChemiDocTM
XRS+ system (Bio-Rad).
Mouse Model of S. suis Meningitis
A hematogenous S. suis meningitis model of infection in CD1
mice has been described previously (Dominguez-Punaro et al.,
2007). Female 6 to 8-week-old CD1 mice (26  2 g, 8 mice
per group) were injected via the tail vein with 5  106 CFUs of
S. suis strains 05ZYH33 or 05ZYH33Dmrp. At day 1, 2, and 3
post-infection, vein blood (10mL) was collected and at day 3 post-
infection, brain tissue was collected aseptically from mice after
euthanasia. Bacterial loads in blood and tissue were determined
by plating serial 10-fold dilutions of the lysates on THB agar. Brain
tissues were fixed in 10% buffered formalin. After embedding in
paraffin, tissue sections were stained with hematoxylin and eosin
and examined by light microscopy.
Evaluation of BBB Permeability
Female 6 to 8-week-old CD1 mice (26  2 g) were randomly
divided into three groups and injected intraperitoneally with
1  107 CFU S. suis 05ZYH33, 05ZYH33Dmrp, or PBS as
previously described (Dominguez-Punaro et al., 2007). At 24, 48,
and 72 h post-infection, mice were injected intraperitoneally with
800 ml of 1% (w/v) Evans Blue dye and perfused transcardially
with PBS 1 h later under anesthesia to remove intravascular Evans
Blue dye. Then, the whole brain was weighed, homogenized,
and the Evans blue dye was extracted as previously described
(Zhang et al., 2010). The extracted supernatant was measured by
absorbance spectroscopy at 620 nm for Evans blue determination.
Calculations were based on external standards in the same
solvent.
Statistical Analysis
The data were analyzed with GraphPad Prism software
using one-way or two-way ANOVA analysis followed by
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FIGURE 3 | S. suis 05ZYH33 infection increases the blood–brain
barrier permeability of mice. (A) Representative images of whole brains
stained by Evans blue dye (days 1, 2, 3). (B) Evans blue extravasations in
brains at day 3 post-infection, data are expressed as mean  SEM, n = 6 in
each group, *P < 0.05.
Bonferroni’s multiple comparison test, or unpaired t-tests
followed by Holm-Sidak method, or by non-parametric Mann-
Whitney t-test. For all tests, a P value < 0.05 was considered
significant.
Results
Binding of MRP to Fibrinogen Promotes
Adherence of S. suis to HCMEC/D3 Cells
Previous studies have found that S. suis serotype 2 has the ability
to adhere to and invade porcine brain microvascular endothelial
cells (Vanier et al., 2004). In this study, we evaluated if hFg could
affect the adherence of S. suis to human brain microvascular
endothelial cells. As shown in Figure 1A, with the increase of hFg,
both wild type strain 05ZYH33 and the 05ZYH33Dmrp mutant
had increased adherence to hCMEC/D3 cells. The adherent
ratio of strain 05ZYH33 was significantly higher than that of
the 05ZYH33Dmrp mutant in the presence of hFg. Fluorescent
microscopy (Figure 1B) showed that in the presence of hFg, there
was significantly more BCECF-labeled S. suis 05ZYH33 than that
of the 05ZYH33Dmrp mutant. These results indicate that the
interaction of MRP and Fg promotes the adherence of S. suis to
hCMEC/D3 cell.
Binding of MRP with Fibrinogen Promotes
Traversal of S. suis Across hCMEC/D3 Cell
Monolayers
The adherence of bacterium to human brain microvascular
endothelial cells is thought to be important for invasion of the
central nervous system (Charland et al., 2000). Since binding of
MRPwith Fg promotes the adherence of S. suis to hCMEC/D3 cell
monolayers, we supposed that this interaction might increase the
traversal of S. suis across hCMEC/D3 cell monolayers. To test this
hypothesis, we pretreated the hCMEC/D3 cell monolayers with
or without Fg before S. suis infection. Our results (Figure 2A)
show that in the presence of hFg (20 mg/mL), both S. suis
strain 05ZYH33 and 05ZYH33Dmrp increased their traversal
abilities across the hCMEC/D3 cell monolayers. The traversal
ratio of strain 05ZYH33 was significantly higher than that of
the mutant strain 05ZYH33Dmrp. The transendothelial cell
permeability assay (Figure 2B) also showed that in the presence of
hFg, wild-type strain 05ZYH33 infection significantly increased
the permeability of Lucifer yellow across the hCMEC/D3 cell
monolayer compared to that of themutant strain 05ZYH33Dmrp.
Combined, these results indicate that the interactions of MRP
and Fg increase the traversal of S. suis across human in vitro
BBB by increasing the permeability of the hCMEC/D3 cell
monolayer.
MRP Contributes to Changes in the Permeability
of the Blood–Brain Barrier
To evaluate the BBB permeability in vivo, we administered
Evans Blue, a dye that is normally excluded from the CNS,
to S. suis 05ZYH33 and Dmrp mutant infected mice through
an intraperitoneal injection at days 1, 2, and 3 post-infection.
Macroscopic inspection of the brain showed more visible
penetration of Evans Blue in S. suis 05ZYH33 infected mice
than that in Dmrp mutant infected mice at day 3 post-infection
(Figure 3A). Quantitative evaluation of extravasated Evans Blue
also revealed higher levels in the brain lysates from S. suis
05ZYH33 infected mice than that from Dmrp mutant infected
mice at day 3 post-infection (Figure 3B). These data show
that MRP might modulate the BBB permeability during the
development of S. suismeningitis.
MRP Promotes the Development of Meningitis
We next evaluated the effects of the MRP-Fg interaction on
the pathogenesis of S. suis meningitis. In this study, CD1 mice
were challenged intravenously with wild type S. suis 05ZYH33
(3.31  106 CFU) and the Dmrp mutant strain (2.94  106
CFU). Bacterial loads in the blood of 05ZYH33 andDmrpmutant
infectedmice were comparable from day 1 to day 3 post-infection,
but bacterial counts in the brains of 05ZYH33 infected mice
at 72 h were significantly higher than that of Dmrp mutant
infected mice (Figure 4A). Histopathological lesions such as
meningeal thickening and neutrophil infiltration were found in
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FIGURE 4 | MRP contributes to the occurrence of S. suis meningitis. (A) Bacterial loads in the blood and brain from CD1 mice infected with S. suis 05ZYH33
or 05ZYH33Dmrp mutant. The difference between the two groups was determined by a Mann-Whitney test. (B,C) Histopathology of representative brain tissues
from CD1 mice infected with S. suis 05ZYH33 (B) and Dmrp mutant (C).
the brains of 05ZYH33 infected mice (Figure 4B) 3 days post-
infection, but not of Dmrp mutant infected mice (Figure 4C).
These data indicate thatMRP promotes the development of S. suis
meningitis.
Binding of MRP to Fibrinogen Can Destroy
p120-Catenin of HCMEC/D3
The above results indicate that the interaction of MRP with Fg
contributes to the development of S. suismeningitis by increasing
the permeability of the BBB. Since the tightness of endothelial cells
ismainly controlled by vascular endothelial cadherin and claudin-
5, we supposed that this interaction might contribute to change
the endothelial cell junctions during the S. suis infection. To test
this hypothesis, we detected the endothelial cell junction proteins
of the hCMEC/D3 cell monolayer challenged with Fg-pretreated
S. suis by western blot. S. suis infection could cause a decrease of
claudin-5, ZO-1, ZO-2, and VE-cadherin 6 h post-infection, but
we observed no significant difference between S. suis 05ZYH33
and 05ZYH33Dmrp infection (data not shown). However, Fg-
pretreated S. suis 05ZYH33 caused a dramatic decrease of p120-
catenin at 25 min post infection, while Fg-pretreated S. suis
05ZYH33Dmrp caused a slight increase of p120-catenin at 25min
post-infection (Figure 5A). Immunofluorescence microscopy
also showed that compared to untreated cells, Fg-pretreated
S. suis 05ZYH33 infection caused a marked decrease in the
amount of p120-catenin on the surface of hCMEC/D3 cells,
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FIGURE 5 | MRP-Fg interaction can destroy p120-catenin of hCMEC/D3. HCMEC/D3 cell monolayers were challenged with Fg pretreated S. suis 05ZYH33 or
05ZYH33Dmrp for the indicated time and the amount of p120-catenin was detected by western blot (A) or by staining for p120-catenin at 25 min post infection (B).
Although we show cropped blots, the gels were run under the same experimental conditions.
while Fg-pretreated S. suis 05ZYH33Dmrp had no significant
change in p120-catenin (Figure 5B). These results indicate that
binding of MRP to Fg could destroy the stability of p120-catenin,
which might contribute to the increased permeability of the
BBB.
Discussion
The interaction of S. suis with the BBB plays an important role
in the pathogenesis of S. suis meningitis. Several in vitro studies
showed that S. suis serotype 2 could adhere to human or porcine
brainmicrovascular endothelial cells (Charland et al., 2000;Vanier
et al., 2004), though only invasion of porcine brain microvascular
endothelial cells was demonstrated (Vanier et al., 2004). Other
studies demonstrated that S. suis acquires plasmin activity when
in contact with cultured human brain microvascular endothelial
cells (hBMECs) and induces the release of arachidonic acid (Jobin
et al., 2005) or the shedding of adhesion molecules from the
cell surface of the hBMECs (Grenier and Bodet, 2008). Our
recent study showed that suilysin from S. suis could remodel the
cytoskeleton of hBMECs by activatingRhoA andRac1GTPase (Lv
et al., 2014).
In this work, we demonstrate that MRP can mediate the
interaction of S. suis with the BBB by binding to the blood
protein fibrinogen. Previously, MRP has been a phenotypic
marker of S. suis virulent strains because MRP is associated
with virulent strains of certain countries. But whether MRP is
a critical virulence factor of S. suis remains controversy because
the function of MRP has not been identified. This study and
our previous studies demonstrate that MRP contribute to the
virulence of S. suis strain 05ZYH33 by binding to Fg (Pian et al.,
2015).
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Many human pathogens can anchor to the cell surface of the
host by serum proteins or extracellular matrix components (Virji
et al., 1995; Sinha et al., 1999; Unkmeir et al., 2002; Schwarz-
Linek et al., 2004) and benefit from these interactions. Our results
demonstrate that MRP binding to Fg significantly increase the
attachment and traversal of S. suis to hBMECs in vitro, which is
likely an essential step for the development of S. suis meningitis.
Our results show that the interaction of MRP with Fg increase the
permeability of the BBB in vitro and in vivo.
Additionally, our results show that the interaction of MRP
with Fg could destroy the stability of the adherens junction
protein p120-catenin. A central function of p120-catenin is
to regulate of intercellular adhesion via controlling the VE-
cadherin hemophilic interactions and maintaining the VE-
cadherin expression level (Reynolds, 2007). Mutant mice lacking
endothelial p120-catenin have decreased VE-cadherin and neural
cadherin levels, as well as a cellular proliferation defect that is
VE-cadherin-dependent, which demonstrates that p120-catenin
is required for vascular development and endothelial function
(Oas et al., 2010). Thus, we speculate that the decrease of p120-
catenin protein caused by the interaction between MRP and
hFg might play an important role in the development of S. suis
meningitis.
In summary, our in vitro and in vivo studies suggest that the
binding of MRP of S. suis serotype 2 to fibrinogen can promote
the adherence and traversal of S. suis across human BMECs, and
can facilitate the development of S. suismeningitis.
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